Top-Rated Stocks: Ligand Pharmaceuticals Sees Composite Rating Climb To 97

Top-Rated Stocks: Ligand Pharmaceuticals Sees Composite Rating Climb To 97

On Wednesday, Ligand Pharmaceuticals got an upgrade for its IBD SmartSelect Composite Rating from 93 to 97.